LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 46 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $138,000 | -26.6% | 43,307 | -1.7% | 0.00% | – |
| Q1 2022 | $188,000 | -40.3% | 44,065 | -34.9% | 0.00% | – |
| Q4 2021 | $315,000 | -25.9% | 67,676 | -36.5% | 0.00% | – |
| Q3 2021 | $425,000 | -61.8% | 106,494 | -59.0% | 0.00% | – |
| Q2 2021 | $1,112,000 | -38.7% | 259,753 | -39.3% | 0.00% | – |
| Q1 2021 | $1,813,000 | +15.3% | 427,683 | +5.5% | 0.00% | – |
| Q4 2020 | $1,572,000 | -56.4% | 405,393 | -54.7% | 0.00% | -100.0% |
| Q3 2020 | $3,605,000 | +26.8% | 894,685 | +34.0% | 0.00% | 0.0% |
| Q2 2020 | $2,844,000 | +6.1% | 667,611 | +4.6% | 0.00% | 0.0% |
| Q1 2020 | $2,680,000 | +78.5% | 638,120 | +67.1% | 0.00% | – |
| Q4 2019 | $1,501,000 | -79.9% | 381,874 | -55.1% | 0.00% | -100.0% |
| Q3 2019 | $7,483,000 | +92.2% | 850,298 | +102.0% | 0.00% | +100.0% |
| Q2 2019 | $3,893,000 | +44.8% | 420,862 | +0.7% | 0.00% | 0.0% |
| Q1 2019 | $2,689,000 | +377.6% | 418,082 | +601.5% | 0.00% | – |
| Q4 2018 | $563,000 | -34.8% | 59,600 | +39.0% | 0.00% | – |
| Q3 2018 | $863,000 | -48.4% | 42,893 | -25.1% | 0.00% | – |
| Q2 2018 | $1,671,000 | +14.7% | 57,287 | +17.1% | 0.00% | – |
| Q1 2018 | $1,457,000 | -14.9% | 48,917 | -8.1% | 0.00% | – |
| Q4 2017 | $1,713,000 | +6.3% | 53,238 | +15.0% | 0.00% | – |
| Q3 2017 | $1,611,000 | -27.1% | 46,312 | -37.6% | 0.00% | -100.0% |
| Q2 2017 | $2,210,000 | -43.0% | 74,232 | -42.8% | 0.00% | 0.0% |
| Q1 2017 | $3,874,000 | -30.2% | 129,770 | -59.0% | 0.00% | 0.0% |
| Q4 2016 | $5,548,000 | +94.0% | 316,454 | +163.3% | 0.00% | 0.0% |
| Q3 2016 | $2,860,000 | +28.9% | 120,210 | -13.3% | 0.00% | 0.0% |
| Q2 2016 | $2,219,000 | +1.1% | 138,661 | +32.2% | 0.00% | 0.0% |
| Q1 2016 | $2,195,000 | -49.5% | 104,926 | -34.9% | 0.00% | -50.0% |
| Q4 2015 | $4,350,000 | -47.7% | 161,117 | -46.2% | 0.00% | -33.3% |
| Q3 2015 | $8,316,000 | +170.4% | 299,212 | +138.4% | 0.00% | +200.0% |
| Q2 2015 | $3,075,000 | +88.1% | 125,486 | +40.5% | 0.00% | 0.0% |
| Q1 2015 | $1,635,000 | +19.1% | 89,330 | +20.0% | 0.00% | 0.0% |
| Q4 2014 | $1,373,000 | +240.7% | 74,435 | +77.4% | 0.00% | – |
| Q3 2014 | $403,000 | +1652.2% | 41,959 | +1578.4% | 0.00% | – |
| Q2 2014 | $23,000 | -76.5% | 2,500 | -72.4% | 0.00% | – |
| Q1 2014 | $98,000 | – | 9,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,914,970 | $81,007,000 | 29.87% |
| RTW INVESTMENTS, LP | 1,080,331 | $30,022,000 | 9.33% |
| Avoro Capital Advisors LLC | 804,299 | $22,351,000 | 5.81% |
| ACUTA CAPITAL PARTNERS, LLC | 122,222 | $3,397,000 | 1.97% |
| Broadfin Capital, LLC | 1,095,373 | $30,440,000 | 1.69% |
| Belmont Global Advisors, Inc. | 35,000 | $973,000 | 1.65% |
| P.A.W. CAPITAL CORP | 48,000 | $1,334,000 | 1.53% |
| Perceptive Advisors | 1,309,030 | $36,378,000 | 1.45% |
| Iguana Healthcare Management, LLC | 125,000 | $3,474,000 | 1.37% |
| EAM Investors, LLC | 97,350 | $2,705,000 | 0.43% |